Low triiodothyronine and survival in end-stage renal disease

Slides:

Advertisements

Similar presentations

Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.

Advertisements

Vitamin D levels and patient outcome in chronic kidney disease

Volume 70, Issue 4, Pages (August 2006)

Bias in clinical research

Beta blockers in the management of chronic kidney disease

Volume 70, Issue 3, Pages (August 2006)

MariLia Bahiense Oliveira, Joao Egidio Romao, Roberto Zatz

Linear and logistic regression analysis

Microalbuminuria, peripheral artery disease, and cognitive function

Mitchell H. Rosner, W. Kline Bolton Kidney International

Volume 83, Issue 3, Pages (March 2013)

Confounding: What it is and how to deal with it

Kidney transplantation in a low-resource setting: Nigeria experience

Volume 61, Issue 2, Pages (February 2002)

Francesco Paolo Schena Kidney International

Volume 70, Pages S21-S25 (December 2006)

Homocysteine and risk in end-stage renal disease: a matter of context

Steven G. Coca, Swathi Singanamala, Chirag R. Parikh

Volume 72, Issue 9, Pages (November 2007)

Volume 67, Issue 6, Pages (June 2005)

Comorbidity and confounding in end-stage renal disease

Proinflammatory effects of iron sucrose in chronic kidney disease

Volume 74, Issue 3, Pages (August 2008)

Volume 70, Issue 11, Pages (December 2006)

G. Tripepi, K.J. Jager, F.W. Dekker, C. Wanner, C. Zoccali

Volume 70, Issue 12, Pages (December 2006)

Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease S. Bianchi, R. Bigazzi, V.M. Campese

The analysis of survival data: the Kaplan–Meier method

Volume 71, Issue 6, Pages (March 2007)

Volume 70, Issue 12, Pages (December 2006)

Analgesic nephropathy

Blood pressure targets in hemodialysis patients

Fructose intake as a risk factor for kidney stone disease

Vitamin D levels and patient outcome in chronic kidney disease

The third World Kidney Day: Looking back and thinking forward

Volume 69, Issue 12, Pages (June 2006)

Volume 69, Issue 3, Pages (February 2006)

Elevated risk of stroke among patients with end-stage renal disease

Volume 71, Issue 6, Pages (March 2007)

Atrial fibrillation in end-stage renal disease: an emerging problem

The global challenge of chronic kidney disease

V.R. Sørensen, P.M. Hansen, J. Heaf, B. Feldt-Rasmussen

Lynda Anne Szczech, Ira L. Lazar Kidney International

A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease S. Susan Hedayati, Venkata Yalamanchili,

Volume 71, Issue 12, Pages (June 2007)

Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors Carmine Zoccali, Francesca Mallamaci,

Volume 70, Issue 3, Pages (August 2006)

Carmine Zoccali, Francesca Mallamaci Kidney International

Organ transplantation goes to the movies

The Iranian model of living renal transplantation

Volume 61, Issue 2, Pages (February 2002)

Volume 70, Issue 7, Pages (October 2006)

Volume 80, Issue 10, Pages (November 2011)

Volume 70, Issue 4, Pages (August 2006)

Is it the low-protein diet or simply the salt restriction?

Treatment of the primary hyperoxalurias: A new chapter

Volume 70, Issue 7, Pages (October 2006)

Charles A. Herzog Kidney International

Volume 70, Issue 3, Pages (August 2006)

Volume 71, Issue 12, Pages (June 2007)

Fetuin-A is not associated with mortality in chronic kidney disease

Volume 70, Issue 5, Pages (September 2006)

Volume 70, Issue 3, Pages (August 2006)

Volume 70, Issue 10, Pages (November 2006)

The International Pediatric Peritonitis Registry: Starting to walk

Volume 69, Issue 8, Pages (April 2006)

In chronic kidney disease staging the use of the chronicity criterion affects prognosis and the rate of progression B.O. Eriksen, O.C. Ingebretsen Kidney.

Familial phenotype differences in PKD11

Prediction in idiopathic membranous nephropathy

Stephen Pastan, J. Michael Soucie, William M. McClellan

Presentation transcript:

Low triiodothyronine and survival in end-stage renal disease C. Zoccali, F. Mallamaci, G. Tripepi, S. Cutrupi, P. Pizzini Kidney International Volume 70, Issue 3, Pages 523-528 (August 2006) DOI: 10.1038/sj.ki.5001566 Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier survival analysis of plasma fT3. Patients are grouped into three tertiles on the basis of individual values of plasma fT3. In parentheses we reported the HR of death (and the 95% CI) associated to each fT3 tertile. Kidney International 2006 70, 523-528DOI: (10.1038/sj.ki.5001566) Copyright © 2006 International Society of Nephrology Terms and Conditions

Figure 2 Hypothetic chain of events leading to death. Reduced fT3 results from inflammation and determines death in ESRD patients. Kidney International 2006 70, 523-528DOI: (10.1038/sj.ki.5001566) Copyright © 2006 International Society of Nephrology Terms and Conditions